Table 5 Review and recurrence of patients’ records
UC patients | Age | Medical history (y) | Extent of the disease | Type D blood flow | Recurrent interval (m) | Maintenance therapy | Treatment changes (Y/N) |
|---|---|---|---|---|---|---|---|
1 | 50 | 12 | E2 | N | 13.7 | 5-ASA | N |
2 | 35 | 15 | E3 | N | 21 | 5-ASA | N |
3 | 65 | 35 | E3 | Y | 7.3 | 5-ASA | Y, Pred |
4 | 45 | 5 | E3 | N | 21 | AZA | N |
5 | 75 | 5 | E2 | N | 22 | 5-ASA | N |
6 | 67 | 32 | E3 | Y | 9.5 | 5-ASA | N |
7 | 22 | 3 | E3 | Y | 9.7 | AZA | Y, anti-TNF |